Novavax, Inc (NVAX) is a leading biotechnology business based in the US. It opened the day at $183.12 after a previous close of $184.00. During the day the price has varied from a low of $178.10 to a high of $186.34. The latest price was $179.33 (25 minute delay). Novavax is listed on the NASDAQ and employs 792 staff. All prices are listed in US Dollars.
How to buy shares in Novavax
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NVAX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Novavax stock price (NASDAQ: NVAX)Use our graph to track the performance of NVAX stocks over time.
Novavax shares at a glance
|52-week range||$76.59 - $331.68|
|50-day moving average||$195.19|
|200-day moving average||$194.39|
|Wall St. target price||$271.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-8.60|
Buy Novavax shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Novavax stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Novavax price performance over time
|1 week (2021-07-21)||N/A|
|1 month (2021-07-01)||-16.88%|
|3 months (2021-04-30)||-24.31%|
|6 months (2021-01-28)||N/A|
|1 year (2020-07-28)||N/A|
|2 years (2019-07-28)||N/A|
|3 years (2018-07-28)||N/A|
|5 years (2016-07-28)||N/A|
|Revenue TTM||$919.4 million|
|Gross profit TTM||$-271,429,000|
|Return on assets TTM||-25.53%|
|Return on equity TTM||-121.19%|
|Market capitalisation||$13.6 billion|
TTM: trailing 12 months
Shorting Novavax shares
There are currently 6.1 million Novavax shares held short by investors – that's known as Novavax's "short interest". This figure is 0.5% down from 6.1 million last month.
There are a few different ways that this level of interest in shorting Novavax shares can be evaluated.
Novavax's "short interest ratio" (SIR)
Novavax's "short interest ratio" (SIR) is the quantity of Novavax shares currently shorted divided by the average quantity of Novavax shares traded daily (recently around 4.2 million). Novavax's SIR currently stands at 1.43. In other words for every 100,000 Novavax shares traded daily on the market, roughly 1430 shares are currently held short.
However Novavax's short interest can also be evaluated against the total number of Novavax shares, or, against the total number of tradable Novavax shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Novavax's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Novavax shares in existence, roughly 80 shares are currently held short) or 0.0825% of the tradable shares (for every 100,000 tradable Novavax shares, roughly 83 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Novavax.
Find out more about how you can short Novavax stock.
Novavax share dividends
We're not expecting Novavax to pay a dividend over the next 12 months.
Have Novavax's shares ever split?
Novavax's shares were split on a 1:20 basis on 9 May 2019. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Novavax shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Novavax shares which in turn could have impacted Novavax's share price.
Novavax share price volatility
Over the last 12 months, Novavax's shares have ranged in value from as little as $76.5913 up to $331.68. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Novavax's is 1.5996. This would suggest that Novavax's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Novavax, Inc. , a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. In addition, the company develops vaccine candidates for the protection against middle east respiratory syndrome, as well as that is in preclinical work associated with severe acute respiratory syndrome; and ebola virus glycoprotein vaccine candidate, as well as COVID-19 vaccine for variant strain. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc.
Stocks similar to Novavax
Novavax in the news
Doctor on Delta variant: ’All of us are extremely concerned’
Don’t Buy Novavax Until Its Covid-19 Vaccine Wins FDA Approval
Don't Buy Novavax Until Its Covid-19 Vaccine Wins FDA Approval
Frequently asked questionsWhat percentage of Novavax is owned by insiders or institutions?
Currently 0.553% of Novavax shares are held by insiders and 59.455% by institutions. How many people work for Novavax?
Latest data suggests 792 work at Novavax. When does the fiscal year end for Novavax?
Novavax's fiscal year ends in December. Where is Novavax based?
Novavax's address is: 21 Firstfield Road, Gaithersburg, MD, United States, 20878 What is Novavax's ISIN number?
Novavax's international securities identification number is: US6700024010 What is Novavax's CUSIP number?
Novavax's Committee on Uniform Securities Identification Procedures number is: 670002104
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert